title: Results from the US industry-wide phosgene surveillance: the Diller Registry.
abstract: OBJECTIVE
  In 2004, The American Chemistry Council Phosgene Panel established a phosgene exposure registry among US phosgene producers with the primary purpose of monitoring health outcome information for workers with acute exposure.
  
  
  METHODS
  We examine symptoms among 338 workers with phosgene exposure. The phosgene exposures averaged 8.3 ppm-minutes ranging up to 159 ppm-minutes with most exposures below 10 ppm-minutes.
  
  
  RESULTS
  We found that the level of phosgene exposure in ppm-minutes was related to workers reporting mostly irritation symptoms of the nose, throat and eyes within 48 hours of exposure. However, we found no relationship between phosgene exposure and the presence of symptoms 30 days after exposure.
  
  
  CONCLUSIONS
  These findings lend credence to the theory that prolonged respiratory effects do not occur with doses less than 150 ppm-minutes.
authors.affiliation: Dow Chemical Company, Midland, MI 48674, USA. jjcollins@dow.com
authors.forename: James J
authors.initials: JJ
authors.lastname: Collins
authors.forename: Donald M
authors.initials: DM
authors.lastname: Molenaar
authors.forename: Larry O
authors.initials: LO
authors.lastname: Bowler
authors.forename: Tom J
authors.initials: TJ
authors.lastname: Harbourt
authors.forename: Michael
authors.initials: M
authors.lastname: Carson
authors.forename: Bipin
authors.initials: B
authors.lastname: Avashia
authors.forename: Teresa
authors.initials: T
authors.lastname: Calhoun
authors.forename: Craig
authors.initials: C
authors.lastname: Vitrano
authors.forename: Paul
authors.initials: P
authors.lastname: Ameis
authors.forename: Richard
authors.initials: R
authors.lastname: Chalfant
authors.forename: Pete
authors.initials: P
authors.lastname: Howard
mesh_terms: D000328:Adult; D002617:Chemical Industry; D005260:Female; D006801:Humans; D019570:Inhalation Exposure / Q000009:adverse effects* / Q000032:analysis / Q000706:statistics & numerical data*; D008297:Male; D016273:Occupational Exposure / Q000009:adverse effects* / Q000032:analysis / Q000706:statistics & numerical data*; D010705:Phosgene / Q000009:adverse effects*; D011159:Population Surveillance; D011654:Pulmonary Edema / Q000139:chemically induced; D012042:Registries; D013997:Time Factors; D014481:United States
chemical_list: D010705:Phosgene